Emerging therapeutic targets in asthma: the rationale for mast cell tryptase inhibition

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.3, Iss.2, 1999-06, pp. : 203-212

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mast Cell Chymase and Tryptase as Targets for Cardiovascular and Metabolic Diseases

Current Pharmaceutical Design, Vol. 19, Iss. 6, 2013-02 ,pp. : 1114-1125

Bentham Science Publishers

Access to resources Recommend Favorite

Emerging therapeutic targets in asthma: a role for interleukin-9

By Levitt R.C. Nicolaides N.C.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 41-51

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic targets in asthma: immunomodulatory cytokines and their delivery

By Cerasoli F.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 27-39

Informa Healthcare

Access to resources Recommend Favorite

Emerging therapeutic cell wall targets in fungal infections

By Selitrennikoff C.P. Ostroff G.R.

Expert Opinion on Therapeutic Targets, Vol. 3, Iss. 1, 1999-03 ,pp. : 53-72

Informa Healthcare

Access to resources Recommend Favorite

Human mast cell tryptase: a stimulus of microvascular leakage and mast cell activation

By He S. Walls A.F.

European Journal of Pharmacology, Vol. 328, Iss. 1, 1997-09 ,pp. : 89-97

Elsevier

Access to resources Recommend Favorite